Evaluation of the safety and immunogenicity of pneumococcal seven-valent conjugate vaccine (Prevenar®) administered in previously unvaccinated Spanish children aged 24 to 36 months

DOI: 10.1016/j.vaccine.2004.10.024 Publication Date: 2004-12-13T22:57:31Z